Retrospective Study of IDegLira, a New Fixed-Ratio Combination, in Japanese Patients With Type 2 Diabetes Mellitus: Analysis of Background Factors Affecting Effectiveness After 6 Months of Treatment

CONCLUSION: In this study, initiation of IDegLira in a real-world clinical setting was beneficial in lowering HbA1c in Japanese T2DM patients with inadequate glycemic control with existing therapy.PMID:37822852 | PMC:PMC10563818 | DOI:10.14740/jocmr4995

Source: Clin Med Res - October 12, 2023 Category: Research Authors: Hodaka Yamada Jun Morimoto Shunsuke Funazaki Shiori Tonezawa Asuka Takahashi Masashi Yoshida Shuichi Nagashima Kazuo Hara Source Type: research